• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. BD POSIFLUSH¿ SF SALINE SYRINGE; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. BD POSIFLUSH¿ SF SALINE SYRINGE; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 306553
Device Problems Material Discolored (1170); Packaging Problem (3007)
Patient Problem No Information (3190)
Event Date 05/01/2018
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd posiflush¿ sf saline syringe package has water stains and some are faint stains.Found before use.No reports of serious injury or medical intervention noted.
 
Manufacturer Narrative
Investigation summary: seven picture samples were received for evaluation by our quality engineer team.Upon examination of the pictures, discoloration was observed on the packaging.A device history record review revealed no anomalies during the production of the provided lot number that could have contributed to this issue.Microbial permeability testing, cytotoxicity testing, and testing for residual solvents and volatile species has been completed on the packages displaying the brownish stains.The testing confirmed that they do not present any risk to the use of the product and have no impact on the effectiveness, sterility, quality or safety of bd posiflushtm sf 10ml saline flush syringe.This is a cosmetic issue only.These products are safe for use.The integrity of the product and the sterile barriers has not been affected.The brownish spots on the packaging were created during the steam sterilization process.These spots appear only on the outside of the packaging and do not permeate in any way onto the product.We are currently exploring several options to reduce and eliminate any brown staining that occurs on the packaging.The product continues to be safe for use.Capa: (b)(4) has been raised to deal with the staining issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH¿ SF SALINE SYRINGE
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
MDR Report Key7515846
MDR Text Key108492149
Report Number9616657-2018-00021
Device Sequence Number1
Product Code NGT
UDI-Device Identifier00382903065530
UDI-Public00382903065530
Combination Product (y/n)N
PMA/PMN Number
K153481
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 05/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date08/31/2020
Device Catalogue Number306553
Device Lot Number7244896
Initial Date Manufacturer Received 05/01/2018
Initial Date FDA Received05/15/2018
Supplement Dates Manufacturer Received05/01/2018
Supplement Dates FDA Received05/29/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-